Merck's headquarters is in Kenilworth, New Jersey, and was founded in 1891. Given GlaxoSmithKline plc (GSK.L)'s stronger consensus rating and higher probable upside, equities analysts clearly believe GlaxoSmithKline plc (GSK.L) is more favorable than Hutchison China MediTech. SWOT analysis of GlaxoSmithKline Pharmaceuticals Ltd analyses the brand/company with its strengths, weaknesses, opportunities & threats. This is a breakdown of recent recommendations for GlaxoSmithKline plc (GSK.L) and AstraZeneca, as reported by MarketBeat. Given Eco Animal Health Group's stronger consensus rating and higher possible upside, analysts plainly believe Eco Animal Health Group is more favorable than GlaxoSmithKline plc (GSK.L). Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Fisker Inc (NYSE:SPAQ) Stock: The Next Big Player in EV? GlaxoSmithKline plc (GSK.L) currently has a consensus target price of GBX 1,815.19, indicating a potential upside of 29.27%. [])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![])+(+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![])+(+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])-[])+(!+[]+(!![])-[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(+!! This table compares GlaxoSmithKline plc (GSK.L) and Beximco Pharmaceuticals Limited (BXP.L)'s revenue, earnings per share and valuation. This is a breakdown of recent recommendations and price targets for GlaxoSmithKline plc (GSK.L) and Dechra Pharmaceuticals, as reported by MarketBeat. In 2008, the pharmaceutical segment contributed 83.7% to GSK's tu… Should you be buying GSK stock or one of its competitors? GlaxoSmithKline plc (GSK.L) is clearly the better dividend stock, given its higher yield and lower payout ratio. This table compares Eco Animal Health Group and GlaxoSmithKline plc (GSK.L)'s top-line revenue, earnings per share and valuation. GlaxoSmithKline PLC Common Stock (GSK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Eco Animal Health Group currently has a consensus price target of GBX 430, indicating a potential upside of 107.05%. [])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![])+(+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])-[])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!! [])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]-(!![]))+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+[])+(+!![])+(!+[]-(!![]))+(!+[]+(!![])-[])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!! [])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![])+(+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![])+(+!![]))/+((!+[]+(!![])+!![]+[])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(+!![])+(!+[]+(!! Given GlaxoSmithKline plc (GSK.L)'s higher probable upside, equities analysts clearly believe GlaxoSmithKline plc (GSK.L) is more favorable than Dechra Pharmaceuticals. GlaxoSmithKline plc (GSK.L) is trading at a lower price-to-earnings ratio than Dechra Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. GlaxoSmithKline plc (GSK.L) presently has a consensus target price of GBX 1,815.19, suggesting a potential upside of 29.27%. We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends. Your browser will redirect to your requested content shortly. We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation. Learn more. Please enable Cookies and reload the page. Want to see which stocks are moving? This table compares GlaxoSmithKline plc (GSK.L) and AstraZeneca's revenue, earnings per share and valuation. [])-[])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![])+(+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![]+!![]+!![]+!! [])). Dechra Pharmaceuticals has a consensus target price of GBX 3,077.50, indicating a potential downside of 10.95%. [])-[])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]-(!![]))+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!! GlaxoSmithKline plc (GSK.L) pays out 57.3% of its earnings in the form of a dividend. Do Not Sell My Information. View our full suite of financial calendars and market data tables, all for free. Eco Animal Health Group (LON:EAH) and GlaxoSmithKline plc (GSK.L) (LON:GSK) are both medical companies, but which is the better business? GlaxoSmithKline plc (GSK.L) beats Dechra Pharmaceuticals on 6 of the 9 factors compared between the two stocks. Please enable Cookies and reload the page. We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends. Compare GSK to its competitors by revenue, employee growth and other metrics at Craft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laxoSmithKline plc (GSK.L) pays an annual dividend of GBX 76 per share and has a dividend yield of 5.4%. GlaxoSmithKline plc (GSK.L) pays an annual dividend of GBX 76 per share and has a dividend yield of 5.4%. This table compares GlaxoSmithKline plc (GSK.L) and Vectura Group's net margins, return on equity and return on assets. GlaxoSmithKline plc (GSK.L) pays out 57.3% of its earnings in the form of a dividend. [])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![])+(+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![])+(+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]-(!![]))+(+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!! All rights reserved. GSK, a world leading healthcare company specialized in research and manufacturing of pharmaceutical and consumer health related products, operates through two main business segments in over 114 countries. []))), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]-(!![]))+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]))/+((+!![]+[])+(+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!! Learn everything you need to know about successful options trading with this three-part video course. This is a summary of current recommendations for GlaxoSmithKline plc (GSK.L) and Beximco Pharmaceuticals Limited (BXP.L), as reported by MarketBeat.com. Should you be buying GSK stock or one of its competitors? Learn about financial terms, types of investments, trading strategies and more. Export data to Excel for your own analysis. GlaxoSmithKline plc (GSK.L) (LON:GSK) and AstraZeneca (LON:AZN) are both large-cap medical companies, but which is the better stock? © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Beximco Pharmaceuticals Limited (BXP.L) pays an annual dividend of GBX 1 per share and has a dividend yield of 1.8%. GlaxoSmithKline plc (GSK.L) beats Eco Animal Health Group on 5 of the 9 factors compared between the two stocks. [])-[])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![])+(+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]+!![]+!! [])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]-(!![]))+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]))/+((+!![]+[])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!!
Goosfraba Seinfeld,
Janssen-cilag Limited Uk,
Kate Humble New Tv Show,
Duane Chase Net Worth,
Adelaide Oval Facts,
Roman Polanski Wife,
Eliminatorias Qatar 2022 Sudamérica Calendario,
University Of Buffalo Football Roster 2017,
Joe Louis Vs Max Schmeling,